A phase I clinical trial of 12- O-tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignancies

Author： Schaar Dale   Goodell Lauri   Aisner Joseph   Cui Xiao   Han Zheng   Chang Richard   Martin John   Grospe Stephanie   Dudek Liesel   Riley Joan   Manago Jacqueline   Lin Yong   Rubin Eric   Conney Allan   Strair Roger  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.57, Iss.6, 2006-06, pp. : 789-795

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase I clinical trial of 7-cyanoquinocarcinol (DX-52-1) in adult patients with refractory solid malignancies

By Bunnell Craig   Supko Jeffrey   Eder Joseph   Clark Jeffrey   Lynch Thomas   Kufe Donald   Shulman Lawrence  

Cancer Chemotherapy and Pharmacology, Vol. 48, Iss. 5, 2001-11 ,pp. : 347-355

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of GTI-2040, a ribonucleotide reductase antisense, with high dose cytarabine in patients with relapsed/refractory acute myeloid leukemia

By Klisovic Rebecca B.   Blum William   Liu Zhongfa   Xie Zhiliang   Kefauver Cheryl   Huynh Lenguyen   Zwiebel James A.   Devine Steven M.   Byrd John C.   Grever Michael R.   Chan Kenneth K.   Marcucci Guido  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1332-1336

Informa Healthcare

Access to resources Recommend Favorite

A Phase I Study of Arsenic Trioxide (Trisenox), Ascorbic Acid, and Bortezomib (Velcade) Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma

By Held Lauren A.   Rizzieri David   Long Gwynn D.   Gockerman Jon P.   Diehl Louis F.   Castro Carlos M. de   Moore Joseph O.   Horwitz Mitchell E.   Chao Nelson J.   Gasparetto Cristina  

Cancer Investigation, Vol. 31, Iss. 3, 2013-03 ,pp. : 172-176

Informa Healthcare

Access to resources Recommend Favorite

Phase I trial of liposomal doxorubicin and ZD1839 in patients with refractory gynecological malignancies or metastatic breast cancer

By Campos Susana   Berlin Suzanne   Parker Leroy   Chen Wendy   Bunnell Craig   Atkinson Tina   Lee Julie   Matulonis Ursula   Hirsch Michelle   Harris Lyndsay   Krasner Carolyn  

International Journal of Clinical Oncology, Vol. 15, Iss. 4, 2010-08 ,pp. : 390-398

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of the antifolate ZD9331 in combination with cisplatin in patients with refractory solid malignancies

By Bilenker Joshua   Stevenson James   Flaherty Keith   Algazy Kenneth   McLaughlin Kathy   Haller Daniel   Giantonio Bruce   Koehler M.   Garcia-Vargas J.   O’Dwyer Peter  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 4, 2004-04 ,pp. : 357-360

Springer Publishing Company

Access to resources Recommend Favorite